Ontology highlight
ABSTRACT:
SUBMITTER: Bilusic M
PROVIDER: S-EPMC5690854 | biostudies-literature | 2017 Nov
REPOSITORIES: biostudies-literature
Bilusic Marijo M Madan Ravi A RA Gulley James L JL
Clinical cancer research : an official journal of the American Association for Cancer Research 20170629 22
In the last few years, immunotherapy has become an important cancer treatment modality, and although the principles of immunotherapy have evolved over many decades, the FDA approvals of sipuleucel-T and ipilimumab began a new wave in immuno-oncology. Despite the current enthusiasm, it is unlikely that any of the immunotherapeutics alone can dramatically change prostate cancer outcomes, but combination strategies are more promising and provide a reason for optimism. Several completed and ongoing ...[more]